These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1000 related articles for article (PubMed ID: 33279302)

  • 1. Metabolomics analysis of microbiota-gut-brain axis in neurodegenerative and psychiatric diseases.
    Konjevod M; Nikolac Perkovic M; Sáiz J; Svob Strac D; Barbas C; Rojo D
    J Pharm Biomed Anal; 2021 Feb; 194():113681. PubMed ID: 33279302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass spectrometry-based metabolomics: Targeting the crosstalk between gut microbiota and brain in neurodegenerative disorders.
    Luan H; Wang X; Cai Z
    Mass Spectrom Rev; 2019 Jan; 38(1):22-33. PubMed ID: 29130504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shedding light on biological sex differences and microbiota-gut-brain axis: a comprehensive review of its roles in neuropsychiatric disorders.
    Shobeiri P; Kalantari A; Teixeira AL; Rezaei N
    Biol Sex Differ; 2022 Mar; 13(1):12. PubMed ID: 35337376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders.
    Chen Y; Xu J; Chen Y
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34205336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of gut microbiota on neuropsychiatric disorders.
    Cenit MC; Sanz Y; Codoñer-Franch P
    World J Gastroenterol; 2017 Aug; 23(30):5486-5498. PubMed ID: 28852308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise, diet and stress as modulators of gut microbiota: Implications for neurodegenerative diseases.
    Gubert C; Kong G; Renoir T; Hannan AJ
    Neurobiol Dis; 2020 Feb; 134():104621. PubMed ID: 31628992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unravelling the potential of gut microbiota in sustaining brain health and their current prospective towards development of neurotherapeutics.
    Banerjee A; Pradhan LK; Sahoo PK; Jena KK; Chauhan NR; Chauhan S; Das SK
    Arch Microbiol; 2021 Aug; 203(6):2895-2910. PubMed ID: 33763767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases.
    Ghaisas S; Maher J; Kanthasamy A
    Pharmacol Ther; 2016 Feb; 158():52-62. PubMed ID: 26627987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome.
    Bicknell B; Liebert A; Borody T; Herkes G; McLachlan C; Kiat H
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiome influences on neuro-immune interactions in neurodegenerative disease.
    Menees KB; Otero BA; Tansey MG
    Int Rev Neurobiol; 2022; 167():25-57. PubMed ID: 36427957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the microbiota-gut-brain axis in neuropsychiatric disorders.
    Generoso JS; Giridharan VV; Lee J; Macedo D; Barichello T
    Braz J Psychiatry; 2021; 43(3):293-305. PubMed ID: 32667590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Microbiota-Gut-Brain Axis in Psychiatric Disorders.
    Góralczyk-Bińkowska A; Szmajda-Krygier D; Kozłowska E
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders.
    Gupta R; Advani D; Yadav D; Ambasta RK; Kumar P
    Mol Neurobiol; 2023 Nov; 60(11):6476-6529. PubMed ID: 37458987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiota-Brain-Gut Axis and Neurodegenerative Diseases.
    Quigley EMM
    Curr Neurol Neurosci Rep; 2017 Oct; 17(12):94. PubMed ID: 29039142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated metagenomics and metabolomics approach implicates the microbiota-gut-brain axis in the pathogenesis of Huntington's disease.
    Kong G; Ellul S; Narayana VK; Kanojia K; Ha HTT; Li S; Renoir T; Cao KL; Hannan AJ
    Neurobiol Dis; 2021 Jan; 148():105199. PubMed ID: 33249136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Therapeutic Drugs from Bioactive Natural Molecules: The Role of Gut Microbiota Metabolism in Neurodegenerative Diseases.
    Di Meo F; Donato S; Di Pardo A; Maglione V; Filosa S; Crispi S
    Curr Drug Metab; 2018; 19(6):478-489. PubMed ID: 29623833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the Gut Microbiome in Autism Spectrum Disorders.
    Pulikkan J; Mazumder A; Grace T
    Adv Exp Med Biol; 2019; 1118():253-269. PubMed ID: 30747427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Possible Role of the Microbiota-Gut-Brain-Axis in Autism Spectrum Disorder.
    Srikantha P; Mohajeri MH
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the gut-brain Axis: Potential therapeutic impact of Psychobiotics on mental health.
    Cocean AM; Vodnar DC
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Aug; 134():111073. PubMed ID: 38914414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A narrative review of relationship between gut microbiota and neuropsychiatric disorders: mechanisms and clinical application of probiotics and prebiotics.
    Yang H; Liu Y; Cai R; Li Y; Gu B
    Ann Palliat Med; 2021 Feb; 10(2):2304-2313. PubMed ID: 33549028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.